Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
Buy
58
MKKGY Quote, Financials, Valuation and Earnings
Last price:
$27.39
Seasonality move
:
4.01%
Day range:
$26.68 - $27.25
52-week range:
$24.32 - $39.17
Dividend yield:
1.74%
P/E ratio:
19.54x
P/S ratio:
2.57x
P/B ratio:
1.89x
Volume:
99.1K
Avg. volume:
153.9K
1-year change:
-13.7%
Market cap:
$58.9B
Revenue:
$22.9B
EPS (TTM):
$1.39
Analysts' Opinion
-
Consensus RatingMerck KGaA has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.10, Merck KGaA has an estimated upside of 36.95% from its current price of $27.09.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $27.09.
Fair Value
-
According to the consensus of 1 analyst, Merck KGaA has 36.95% upside to fair value with a price target of $37.10 per share.
MKKGY vs. S&P 500
-
Over the past 5 trading days, Merck KGaA has overperformed the S&P 500 by 0.91% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Merck KGaA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merck KGaA has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Merck KGaA reported revenues of $5.8B.
Earnings Growth
-
Merck KGaA has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Merck KGaA reported earnings per share of $0.33.
Enterprise value:
66B
EV / Invested capital:
--
Price / LTM sales:
2.57x
EV / EBIT:
15.92x
EV / Revenue:
2.89x
PEG ratio (5yr expected):
--
EV / Free cash flow:
25.40x
Price / Operating cash flow:
22.63x
Enterprise value / EBITDA:
10.23x
Gross Profit (TTM):
$13.5B
Return On Assets:
5.57%
Net Income Margin (TTM):
13.14%
Return On Equity:
9.8%
Return On Invested Capital:
7.21%
Operating Margin:
22.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $23.4B | $22.7B | $22.9B | $5.6B | $5.8B | |
| Gross Profit | $14.4B | $13.4B | $13.5B | $3.1B | $3.3B | |
| Operating Income | $5B | $3.9B | $4.3B | $588M | $1.3B | |
| EBITDA | $6.9B | $6.2B | $6.5B | $1.3B | $1.5B | |
| Diluted EPS | $1.61 | $1.41 | $1.39 | $0.29 | $0.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.4B | $12.4B | $13.1B | $13.7B | $14B | |
| Total Assets | $51.4B | $51.4B | $52B | $53.6B | $53.7B | |
| Current Liabilities | $11.4B | $11.8B | $10.2B | $9.6B | $11.8B | |
| Total Liabilities | $30.5B | $27.1B | $24.2B | $24B | $22.5B | |
| Total Equity | $20.9B | $24.2B | $27.9B | $29.6B | $31.2B | |
| Total Debt | $14.3B | $11.7B | $10.6B | $10.3B | $9.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.5B | $4.1B | $5B | $1.1B | $1.3B | |
| Cash From Investing | -$2.9B | -$2B | -$3.3B | -$479.4M | -$642.9M | |
| Cash From Financing | -$1.6B | -$1.9B | -$1.1B | -$1B | -$1.4B | |
| Free Cash Flow | $2.6B | $1.9B | $2.6B | $500.9M | $752.1M | |
MKKGY
Sector
Market Cap
$58.9B
$34.9M
Price % of 52-Week High
69.16%
42.85%
Dividend Yield
1.74%
0%
Shareholder Yield
--
-0.82%
1-Year Price Total Return
-13.7%
-40.42%
Beta (5-Year)
1.008
0.738
Dividend yield:
1.74%
Annualized payout:
$0.47
Payout ratio:
10.22%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$26.50
200-day SMA
Sell
Level
$31.80
Bollinger Bands (100)
Sell
Level
27.44 - 30.12
Chaikin Money Flow
Buy
Level
6.5M
20-day SMA
Buy
Level
$26.65
Relative Strength Index (RSI14)
Sell
Level
49.95
ADX Line
Sell
Level
17.8
Williams %R
Sell
Level
-10.0649
50-day SMA
Sell
Level
$27.96
MACD (12, 26)
Sell
Level
-0.48
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
566.6K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9943)
Buy
CA Score
(Annual)
Level (0.3493)
Buy
Beneish M-Score
(Annual)
Level (-2.7153)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.0694)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Stock Forecast FAQ
In the current month, MKKGY has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MKKGY average analyst price target in the past 3 months is $37.10.
-
Where Will Merck KGaA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merck KGaA share price will rise to $37.10 per share over the next 12 months.
-
What Do Analysts Say About Merck KGaA?
Analysts are divided on their view about Merck KGaA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merck KGaA is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Merck KGaA's Price Target?
The price target for Merck KGaA over the next 1-year time period is forecast to be $37.10 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MKKGY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merck KGaA is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of MKKGY?
You can purchase shares of Merck KGaA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merck KGaA shares.
-
What Is The Merck KGaA Share Price Today?
Merck KGaA was last trading at $27.39 per share. This represents the most recent stock quote for Merck KGaA. Yesterday, Merck KGaA closed at $27.09 per share.
-
How To Buy Merck KGaA Stock Online?
In order to purchase Merck KGaA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
56
ROOT alert for Apr 23
Root [ROOT] is up 9.37% over the past day.
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 1.69% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is down 1.81% over the past day.
